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A major drawback of current whole-cell vaccines for Mycobacterium avium subsp. paratuberculosis is the
interference with diagnostic tests for bovine tuberculosis (TB) and paratuberculosis. The current study was
designed to explore the effects of immunization with a heat-killed whole-cell vaccine (Mycopar) on diagnostic
test performance and to characterize host immune responses to vaccination over a 12-month period. Neonatal
dairy calves were assigned to treatment groups consisting of (i) controls, not vaccinated (n  5), and (ii)
vaccinates, vaccinated with Mycopar vaccine (n  5). The results from this study demonstrated a rapid
initiation of M. avium subsp. paratuberculosis-specific gamma interferon (IFN-) in vaccinated calves by 7 days,
with robust responses throughout the study. Vaccinated calves also had responses to M. bovis purified protein
derivative tuberculin (BoPPD) but minimal reactivity to ESAT-6/CFP-10, an M. bovis recombinant fusion
protein. The levels of antigen-specific interleukin-4 (IL-4) and IL-10 were markedly decreased in vaccinated
calves between days 7 and 90 of the study but thereafter were similar to the levels in controls. Vaccinated calves
began to seroconvert at 4 months, with 4/5 calves having detectable M. avium subsp. paratuberculosis antibody
by 6 months. The responses in test platforms for bovine TB were negligible in the vaccinate group, as only one
calf had a response, which was in the suspect range of the comparative cervical skin test. Serum antibody
responses to M. bovis antigens ESAT-6, CFP-10, and MPB83 were negative on the Vet TB STAT-PAK, DPP
VetTB, and DPP BovidTB tests. These results suggest that the Mycopar vaccine will interfere with diagnostic
tools for paratuberculosis but result in low interference with the comparative cervical skin test and emerging
serologic tests for M. bovis.
Vaccination has proven to be effective in reducing the My-
cobacterium avium subsp. paratuberculosis tissue burden in in-
fected animals (28). It has also been shown to be effective in
reducing fecal shedding, thereby controlling the spread of dis-
ease within and between herds (14). Vaccination also alleviates
signs of clinical disease, so it is helpful in allaying losses asso-
ciated with reproductive problems and reduced milk produc-
tion (13, 32). One major disadvantage to using a whole-cell
vaccine is the inability of standard serologic diagnostic tests for
bovine paratuberculosis to distinguish vaccinates from M.
avium subsp. paratuberculosis-infected animals (8, 19). It has
been shown that whole-cell vaccines for M. avium subsp. para-
tuberculosis will trigger both Th1- and Th2-mediated immune
responses, as demonstrated by antigen-specific gamma inter-
feron (IFN-) responses and M. avium subsp. paratuberculosis-
specific serum antibody, thereby confounding their use as
diagnostic tools for the detection of M. avium subsp. paratu-
berculosis infection (9, 17, 19). However, it is possible that
other immunologic parameters may be useful as screening
tools that can differentiate M. avium subsp. paratuberculosis
infection from vaccination. Recent studies have shown that
vaccination with whole-cell vaccines will elicit increases in CD4
and  T cells and CD4 CD25 T cell populations in recall to
antigen stimulation (9, 22). A more thorough assessment of
host immune responses to vaccination will provide us with
information about protective correlates associated with re-
duced clinical disease.
Another major concern for the use of paratuberculosis vac-
cines is the potential interference with current diagnostics for
bovine tuberculosis (TB). The caudal fold skin test (CFT) is
the most common tuberculin test and is widely used as an
initial screening tool for bovine tuberculosis in the field (10).
The CFT is based upon a response to a singular antigen, M.
bovis purified protein derivative tuberculin (BoPPD). How-
ever, the use of the comparative cervical test (CCT) is recom-
mended as a complementary test to the CFT as it uses a dual
antigen approach (bovine and avian PPDs) to discriminate
between true M. bovis infection and reactivity due to environ-
mental mycobacteria, including M. avium subspecies. Paratu-
berculosis infection has been shown to have a negative effect
on the interpretation of the tuberculin skin test, with elevated
responses to BoPPD compared to those in noninfected cattle,
but little work has been done to evaluate the effects of para-
tuberculosis vaccination on the bovine tuberculin test (1). New
serologic tests for the detection of M. bovis infection have
recently been developed and are demonstrating high levels of
sensitivity and specificity in the detection of bovine tuberculo-
sis (18). However, there are no available data to determine
whether these new serologic test platforms will reduce cross-
reactivity with M. avium subsp. paratuberculosis antigens asso-
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ciated with the paratuberculosis vaccine. The proposed re-
search will explore the cross-reactivity of the current U.S. heat-
killed whole-cell vaccine for M. avium subsp. paratuberculosis
with new serologic diagnostic tools for bovine TB.
MATERIALS AND METHODS
Animals. Neonatal Holstein dairy calves were obtained from herds in Iowa and
Minnesota at 1 to 2 days of age. The farms were status level 4 herds enrolled in
the Voluntary Bovine Johne’s Control Program, with no reportable incidence of
Johne’s disease in the last 4 to 5 years and a 99% probability that they were free
of paratuberculosis. Calves were housed in biosafety level 2 containment barns
for the duration of the study. Calves were allowed to acclimate to their environ-
ment for 1 week prior to the initiation of the study. Standard commercial milk
replacer (Land O Lakes, Shoreview, MN) was fed 2 per day at 10-h intervals
during the first 6 weeks of age, and then calves were weaned onto calf starter
(Kent Feeds, Muscatine, IA) and gradually switched over to a mixed pelleted
ration for the remainder of the study. The treatment groups consisted of (i)
controls, not vaccinated (n  5), and (ii) vaccinates, vaccinated with Mycopar
vaccine (n  5). Blood and fecal samples were collected on 2 consecutive days
prior to the initiation of the study (days 2 and 0) and averaged for prevacci-
nation measurements. Calves were then vaccinated subcutaneously in the dew-
lap-brisket area according to standard procedure with a 0.5-ml dose with the
wild-type commercial vaccine consisting of a heat-killed whole-cell suspension of
M. avium subsp. paratuberculosis in oil (Mycopar, Fort Dodge Animal Health,
Fort Dodge, IA). Calves were sampled throughout the study on days 7, 14, and
28 and at 3, 6, 9, and 12 months. All procedures performed on the animals were
approved by the Institutional Animal Care and Use Committee (National Ani-
mal Disease Center [NADC], Ames, IA).
Blood collection and culture conditions. Peripheral blood mononuclear cells
(PBMCs) were isolated from the buffy coat fractions of blood. PBMCs were
resuspended in complete medium (RPMI-1640 [Gibco, Grand Island, NY] with
10% fetal calf serum [Atlanta Biologics, Atlanta, GA], 100 U of penicillin G
sodium [Gibco] per ml, 100 g of streptomycin sulfate [Gibco] per ml, 0.25 g of
amphotericin B [Gibco] per ml, and 2 mM l-glutamine [Gibco]). Cells were
cultured at 2.0  106/ml in replicate 48-well flat-bottom plates (Corning Incor-
porated, Corning, NY) at 39°C in 5% CO2 in a humidified atmosphere. Dupli-
cate wells were set up for each animal for each in vitro treatment. In vitro
treatments consisted of no stimulation (medium only), 10 g/ml concanavalin A
(ConA; Sigma Chemical Co., St. Louis, MO), 10 g/ml pokeweed mitogen
(PWM; Sigma), 10 g/ml johnin purified protein derivative (JPPD; National
Veterinary Services Laboratory, Ames, IA), 10 g/ml M. bovis purified protein
derivative (BoPPD; NVSL),1 g/ml recombinant ESAT-6/CFP-10 fusion protein
(rEC) from M. bovis (provided by F. C. Minion, Iowa State University), and 10
g/ml of a whole-cell sonicate of strain K-10 of M. avium subsp. paratuberculosis
(MPS). The MPS was prepared by sonication of M. avium subsp. paratuberculosis
(1  109/ml) in phosphate-buffered saline (PBS) at 25 W for 25 min on ice
(Tekmar sonic disturber; Tekmar, Lorton, VA), and the protein concentration
was determined as previously described (26). After 24 h, one set of plates were
removed and centrifuged at 400  g for 5 min. Supernatants were removed
without disturbing the cells in culture and stored at 20°C prior to cytokine
measurement. The replicate set of plates was incubated for 6 days, and cells were
harvested for flow cytometric analyses.
Cytokine analyses of cell culture supernatants. Bovine IFN- was measured
by using the Bovigam test kit (Prionics, La Vista, NE) as described by the
manufacturer. A standard curve was generated using recombinant bovine IFN-
(3.12 to 100 ng/ml; Thermo Scientific, Rockford, IL). Bovine interleukin-10
(IL-10) was quantified by coating MaxiSorp microtiter plates (Nunc, Rochester,
NY) with mouse anti-bovine IL-10 in coating buffer (0.05 M carbonate-bicar-
bonate buffer, pH 9.6 [MCA2110], 2 g/ml; Serotec, Raleigh, NC) overnight at
room temperature (RT). After washing 5 times with PBS containing 1% Tween
80, samples and dilutions of bovine IL-10 standard (0.3125 to 20 ng/ml) (gener-
ous gift from Jayne Hope, Compton, United Kingdom) were added to duplicate
wells and incubated at RT for 1 h. After being washed, plates were incubated
with mouse anti-bovine IL-10–biotin (MCA2111B; Serotec) for 1 h. Plates were
washed again and incubated with avidin-horseradish peroxidase (HRP) conju-
gate (1:800) (PharMingen, San Diego, CA) for 45 min at RT. After another wash
cycle, plates were incubated with substrate solution (40 mM ABTS [2,2-azino-
diethylbenzthiozoline-6-sulfonic acid]; US Biological, Swampscott, MA). Color
development was quantified after 30 min by measuring absorbance at 405 nm
with a Wallac Victor 1420 multilabel counter enzyme-linked immunosorbent
assay (ELISA) plate reader (Perkin-Elmer, Gaithersburg, MD). To quantify
bovine IL-4 in culture supernatants, plates were coated with mouse anti-bovine
IL-4 (clone CC313, 5 g/ml; Serotec) in 0.05 M carbonate-bicarbonate buffer and
incubated overnight at 4°C. After being washed, plates were blocked with PBS
containing 1% bovine serum albumin (BSA) and 0.05% Tween 20 for 1 h at RT.
After being washed, samples and dilutions of the standard (recombinant bovine
IL-4 [PBP006], 15.6 to 2,000 pg/ml; Serotec) were incubated for 1 h at RT,
followed by incubation with mouse anti-bovine IL-4–biotin antibody (clone
CC314, 2.5 g/ml; Serotec) for 1 h at RT, streptavidin-horseradish peroxidase
(1:1,000; GE Healthcare, Piscataway, NJ) for 45 min at RT, and then ABTS
substrate (US Biological) for 1 h at RT, followed by measuring absorbance at 405
nm as described above. Bovine IL-12 was measured by ELISA after coating
plates with mouse anti-bovine IL-12 antibody (MCA1782EL, 8 g/ml; Serotec)
diluted in 0.05 M carbonate-bicarbonate buffer overnight at 4°C. Plates were
then blocked with 1% BSA overnight at 4°C, followed by the addition of samples
and standard dilutions (55 to 1,500 U/ml; kind gift from Jayne Hope, Compton,
United Kingdom), and were incubated for 1 h at RT. This was followed by
incubation with biotinylated anti-bovine IL-12 (MCA2173B, 1 g/ml; Serotec)
for 1 h at RT, incubation with streptavidin-horseradish peroxidase (1:800) and
ABTS substrate for 1 h at RT, and then measurement of absorbance at 405 nm
as described above.
Flow cytometric analysis. Briefly, 6-day culture plates were centrifuged at
1,500 rpm for 5 min and the supernatant was decanted. Cells were gently resus-
pended in 300 l of PBS (0.15 M, pH 7.4). In 96-well round-bottom plates
(Corning Incorporated, Corning, NY), 50-l amounts of the cell suspension were
added to wells containing 50 l of primary monoclonal antibody to CD4, CD8,
and  T cells, B cells, CD25, CD26, CD5, and CD45RO (Table 1). All wells
received 10 g/ml of DAPI (4-6-diamidino-2-phenylindole; Sigma) to differen-
tiate live from dead cells and allow gating on viable cells. Cells were then
incubated at 4°C for 30 min. After incubation, plates were centrifuged at 1,250
rpm for 2 min at 4°C and the supernatant decanted. Amounts of 100 l of
secondary antibody cocktail consisting of fluorescein-conjugated anti-mouse IgM
(Southern Biotech, Birmingham, AL), R-phycoerythrin-conjugated goat F(ab)2
anti-mouse IgG2a (Southern Biotech, Birmingham, AL), and peridinin-chloro-
phyll-protein complex-conjugated rat anti-mouse IgG1 (Becton Dickinson, San
Jose, CA) diluted 1:312, 1:625, and 1:42, respectively, in PBS with 1% fetal calf
serum and 0.04% sodium azide were then added to designated wells, and the
plate was centrifuged again at 1,250 rpm for 2 min at 4°C. The cells were then
suspended in 200 l of BD FACS lyse (BD Biosciences, San Jose, CA) for
immediate flow cytometric analysis. Samples were evaluated using 30,000 events
per sample using a FACScan flow cytometer (CellQuest Software; Becton Dick-
inson). Mononuclear cells, based on forward- and side-scatter characteristics,
were analyzed for cell surface marker expression (FlowJo; Tree Star, Inc., San
Carlos, CA).
Serologic assays. Serum was harvested from whole blood and assayed for the
presence of M. avium subsp. paratuberculosis antibodies by commercial ELISA
(Herdchek) and Western blotting. Electrophoresis and immunoblot assays were
performed using previously reported procedures (2). Briefly, the reactivities of
serum samples from calves against MPS (whole-cell sonicate of M. avium subsp.
paratuberculosis strain K-10) were assessed using the Mini-Protean II slot blot
device (Bio-Rad, Richmond, California). Antigen was electrophoresed through
preparative 12% (wt/vol) polyacrylamide gels and transferred to nitrocellulose
TABLE 1. Primary antibodiesa





CD4 GC50A1 IgM 14 T-helper cell
CD5 B29a IgG2a 7 Activation marker
CD8 BAQ111A IgM 14 T-cytotoxic/suppressor
cell
CD25 CACT116A IgG1 15 IL-2 receptor
CACT108A IgG2a 15
LCTB2A IgG3 15
CD26 CACT114A IgG2b 15 Activation marker
CD45RO GC42A1 IgG1 10 Memory/activation
marker
N12 CACT61A IgM 14 -cell receptor
B cell BAQ155 IgG1 7 Total B cell
a Obtained from VMRD, Inc. (Pullman, WA). MAb, monoclonal antibody.
b Diluted in PBS with 1% fetal calf serum and 0.04% sodium azide.
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filters. These filters were placed in a blocking solution consisting of phosphate-
buffered saline plus 0.1% Tween 20 (PBST) and 2% (wt/vol) bovine serum
albumin (PBST-BSA). After the blocking, the filters were placed into the slot
blot device and individual sera, diluted 1:200 in PBST-BSA, were added to
independent slots. After a 2-h incubation with gentle rocking, the blots were
washed three times with PBST and incubated with horseradish peroxidase-
conjugated anti-goat IgG heavy and light chains (Vector Laboratories, Burlin-
game, CA) diluted 1:20,000 in PBST-BSA for 1.5 h. The blots were again washed
three times with PBST and developed for chemiluminescence in SuperSignal
detection reagent (Thermo Scientific, Rockford, IL).
For detection of M. bovis-specific response, the VetTB STAT-PAK assay, the
dual-path platform (DPP) VetTB assay, and the DPP BovidTB assay (Chembio
Diagnostic Systems, Inc., Medford, NY) were performed as described previously
(11). These immunochromatographic tests use M. bovis antigens, such as
ESAT-6, CFP10, and MPB83, to measure M. bovis antibody (11, 12, 18). The
tests require minimal amounts of serum sample (5 to 30 l), and results are
available within 20 min, by visually monitoring the appearance of bands in the
reaction zone. The use of an optical reader to monitor these tests is optional and
in the present study was unnecessary due to the negative results for vaccinated
calves. All sera were coded and tested blindly.
Skin test. The comparative cervical skin test was performed at 6 months both
as a diagnostic tool and to determine the in vivo cell-mediated response to
vaccination. Skin tests were performed as specified in the “Uniform Methods and
Rules for Bovine Tuberculosis Eradication” circular (APHIS 91-45-011) of the
USDA Animal and Plant Health Inspection Service (30), with minor modifica-
tions. Briefly, skin thickness was measured with calipers immediately prior to and
72 h after injection of M. avium purified protein derivative (AvPPD) and M. bovis
purified protein derivative (BoPPD) to the midcervical region of each animal.
Data are presented as the change in skin thickness (mm) from preinjection
measurements (mean  standard error of the mean [SEM]) for each PPD.
Statistical analyses. Data were analyzed by repeated measures using the
PROC MIXED procedure of the Statistical Analysis System (SAS Institute, Inc.,
Cary, NC). The model included the fixed effects of treatment (vaccination), day
(time after vaccination), and the treatment-times-day interaction, the random
effect of calves nested within treatment, and the residual error. When significant
effects (P 	 0.05) due to treatment, day, or treatment-times-day interactions
were detected, means separation was conducted by using the Tukey-Kramer
option in SAS.
RESULTS
Vaccination with Mycopar resulted in highly significant (P 	
0.01) upregulation of IFN- production by PBMCs in response
to either of the M. avium subsp. paratuberculosis antigen prep-
arations (JPPD or MPS) beginning at 7 days postvaccination
(Fig. 1A and B). Antigen-specific IFN- continued to increase
in a linear fashion up to 30 days and then began to level off. At
6 months (180 days), all calves were administered a compara-
tive cervical skin test, resulting in a boost in IFN- secretion
that lasted throughout the remainder of the study (360 days).
An evaluation of IFN- responses to nonspecific in vitro stim-
ulants (ConA and PWM), as well as M. bovis antigen prepa-
rations (BoPPD and rEC), at 1 and 12 months postvaccination
is presented in Fig. 2. As shown in Fig. 1, both JPPD and MPS
evoked robust responses in vaccinated calves at both time
points. Similar responses in IFN- secretion to BoPPD (P 	
FIG. 1. Secretion of IFN- (ng/ml) by PBMCs of control calves and calves vaccinated with a heat-killed whole-cell Mycobacterium avium subsp.
paratuberculosis vaccine at various time points during the 12-month study when stimulated with johnin purified protein derivative (JPPD) (A) and
with whole-cell sonicate of Mycobacterium avium subsp. paratuberculosis (MPS) (B). Data are expressed as means  SEMs. Significant differences
between treatment group within given time points are represented by asterisks (*, P 	 0.01; **, P 	 0.05). Abs, absorbance.
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0.01) but not to the rEC protein preparation were noted in
vaccinated calves (Fig. 2A and B). Interestingly, treatment
differences were also noted after ConA stimulation of cells,
with higher (P 	 0.01) levels of IFN- for vaccinated calves at
1 month (Fig. 2A) but not at 12 months (Fig. 2B).
An overall trend (P  0.06) for effects due to treatment was
demonstrated in IL-4 secretion, with minimal effects noted due
to stimulation of cells in vitro. After collapsing data from all
time points within an in vitro group, as depicted in Fig. 3, an
upregulation in IL-4 secretion by ConA-stimulated cells and a
downregulation in cells stimulated with MPS (overall signifi-
cance P 	 0.02) in vaccinated calves were noted. Increases in
antigen-mediated IL-4 secretion occurred at 7 and 14 days for
control calves but not vaccinated calves (Fig. 4A). This effect
was consistent after stimulation of cells with either of the M.
avium subsp. paratuberculosis antigen preparations (JPPD or
MPS) (data not shown) but was not observed for cells stimu-
lated with BoPPD or rEC. Interestingly, a similar upregulation
(P 	 0.05) of IL-10 in MPS-stimulated cell cultures was ob-
served between 7 and 90 days of the study for control calves
(Fig. 4B). There were no discernible effects due to vaccination
or in vitro stimulation of cells on the secretion of IL-12 (data
not shown).
Additional immunologic responses to vaccination were char-
acterized by flow cytometric analyses of immune cell subpopu-
lations. Vaccination did not appear to affect CD8 or  pop-
ulations, regardless of the in vitro stimulant used (data not
shown). However, the percentage of total CD4 T cells in
PBMCs stimulated with JPPD was significantly (P 	 0.01)
increased for vaccinated calves within 1 month after vaccina-
FIG. 2. Comparison of in vitro stimulation with medium control
(NS [not stimulated]), concanavalin A (ConA), pokeweed mitogen
(PWM), johnin purified protein derivative (JPPD), whole-cell sonicate
of Mycobacterium avium subsp. paratuberculosis (MPS), bovine puri-
fied protein derivative (BoPPD), and recombinant ESAT-6/CFP10
fusion protein (rEC) on IFN- (ng/ml) secretion by PBMCs isolated
from control calves and calves vaccinated with a heat-killed whole-cell
Mycobacterium avium subsp. paratuberculosis vaccine at 1 month of
infection (A) and 12 months postvaccination (B). Data are expressed
as means  SEMs. Significant differences between treatment groups
are represented by asterisks (*, P 	 0.01; **, P 	 0.05). Abs, absor-
bance.
FIG. 3. Comparison of in vitro stimulation with medium control
(NS), concanavalin A (ConA), pokeweed mitogen (PWM), johnin
purified protein derivative (JPPD), whole-cell sonicate of Mycobacte-
rium avium subsp. paratuberculosis (MPS), bovine purified protein
derivative (BoPPD), and recombinant ESAT-6/CFP10 fusion protein
(rEC) on IL-4 (pg/ml) secretion by PBMCs isolated from control
calves and calves vaccinated with a heat-killed whole-cell Mycobacte-
rium avium subsp. paratuberculosis vaccine. Data are expressed as
means  SEMs. Significant differences between treatment groups are
represented by asterisks (*, P 	 0.01; **, P 	 0.05).
FIG. 4. Secretion of IL-4 (pg/ml) and IL-10 (U/ml) by PBMCs of
control calves and calves vaccinated with a heat-killed whole-cell My-
cobacterium avium subsp. paratuberculosis vaccine when stimulated
with johnin purified protein derivative (JPPD) at various time points
during the 12-month study. Data are expressed as means  SEMs.
Significant differences between treatment groups are represented by
asterisks (*, P 	 0.01; **, P 	 0.05).
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tion (Fig. 5A). A delayed effect of vaccination was observed on
natural killer (NK) cells (CD335
 T cells), which were upregu-
lated at 9 and 12 months in PBMCs stimulated in vitro with M.
avium subsp. paratuberculosis antigens (Fig. 5B; data for JPPD
are shown). Some increases in the percentage of NK cells in
response to BoPPD were also noted at these time points in
vaccinated calves, but no increases were observed for rEC
(data not shown).
Vaccination did result in increased expression of T cell ac-
tivation markers on some immune cell subpopulations. An
upregulation of CD25 expression was observed on T cells stim-
ulated with JPPD within 3 months postvaccination and contin-
ued to increase throughout the study (Fig. 6). In contrast, a
marked (P 	 0.01) increase in antigen-specific CD25 expres-
sion was noted within the CD4
 subpopulation at 1 month,
regardless of vaccination status (Fig. 6B). By 3 months, CD4
CD25 expression had begun to decline for vaccinated calves
but was still upregulated in control animals. At later time
points (6, 9, and 12 months) of the study, CD4 CD25 expres-
sion was significantly (P 	 0.05) higher for vaccinated calves
than for the nonvaccinated controls, in a pattern similar to the
results for the total T cell population. Perhaps more striking
were the results of CD26 activation marker expression on T
cells (Fig. 7A and B). The upregulation of antigen-specific
CD26 expression on total T cells was increased (P 	 0.05)
within 1 month and extended throughout the 12-month study
for vaccinated calves (Fig. 7A). Similarly, within 3 months,
CD26 expression on CD4
 T cells was highly upregulated (P 	
0.05) in vaccinated calves. (Fig. 7B). Although CD26 expres-
sion declined between 3 and 12 months, it was consistently
higher for vaccinated calves. Neither the total B cell popula-
tions nor the B cell subpopulations defined by CD5 and
CD45RO expression were affected when stimulated in vitro
using PWM, a polyclonal activator (Fig. 8). However, vaccina-
tion did result in a decrease (P 	 0.05) in the percentage of B
cells following stimulation of PBMCs with either JPPD or MPS
at 12 months (Fig. 8). Interestingly, an upregulation in CD5
and CD45RO expression on B cells was also noted after anti-
gen stimulation of cells in vitro; however, this effect was only
significant (P 	 0.01) for MPS.
The temporal appearance of M. avium subsp. paratubercu-
losis-specific antibody after vaccination was measured using a
commercial ELISA (Herdchek) and immunoblot. Four of 5
vaccinated calves seroconverted during the 12-month study
FIG. 5. Percentages of CD4 T cells (A) and NK (B) cells within total PBMCs of control calves and calves vaccinated with a heat-killed
whole-cell Mycobacterium avium subsp. paratuberculosis vaccine when stimulated with johnin purified protein derivative (JPPD) at various time
points during the 12-month study. Data are expressed as means  SEMs. Significant differences between treatment groups within given time points
are represented by asterisks (*, P 	 0.01; **, P 	 0.05).
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period, as demonstrated in Fig. 9. Serum antibody was mea-
surable in some vaccinated calves by 3 months postvaccination,
and at 4 months, all calves that eventually seroconverted were
positive. Antibody titers (sample-to-positive ratio) continued
to increase in vaccinated calves throughout the study period.
Immunoblot analyses for calf sera across all time points (0, 7,
14, and 28 days and 3, 6, 9, and 12 months) was performed
using a whole-cell sonicate preparation of M. avium subsp.
paratuberculosis strain K-10 as the antigen to assess the pres-
ence of serum antibodies. Sample blots for a representative
calf from each treatment group are shown (Fig. 10). There was
a distinct difference in the banding pattern due to vaccination
of calves. Banding on blots for control animals was minimal
and occurred between 40 and 50 kDa. In contrast, vaccination
of calves resulted in the appearance of multiple bands ranging
between 20 and 75 kDa. A good portion of these bands ap-
peared between months 3 and 6 of the study, indicative of a
gradual acquisition of antibody upon exposure to the vaccine.
This banding pattern and the time of appearance were consis-
tent among all vaccinated calves except for the one calf that
failed to demonstrate seroconversion with the commercial
ELISA.
We further defined the effects of vaccination on standard
and novel diagnostic tests for M. bovis in cattle to determine
whether use of the vaccine to control M. avium subsp. paratu-
berculosis infections will lead to false-positive TB diagnoses.
The effect of vaccination on the results of a comparative cer-
vical skin test measuring reactivity to M. avium PPD and M.
bovis PPD is presented in Fig. 11. Only the vaccinated calves
demonstrated any reactivity in the skin test, with significantly
higher (P 	 0.01) increases in skinfold thickness noted for both
AvPPD and BoPPD compared to the results for the control
calves (Fig. 11). The reactions to AvPPD (18.9  5.9) were
significantly (P 	 0.01) higher than the BoPPD reactions
(6.9  0.9) in vaccinated calves. Although BoPPD reactivity
was present for vaccinated calves, only one calf fell into the
suspect category, and all other calves were deemed nonreac-
tors (Fig. 12). In addition, all serum reactions to M. bovis
proteins (ESAT-6, CFP-10, and MPB83) using the novel sero-
logic tests VetTB STAT-PAK, DPP VetTB, and DPP BovidTB
were negative (data not shown), with the exception of one
animal in the vaccinate treatment group that was weakly pos-
itive on the VetTB STAT-PAK test.
DISCUSSION
Vaccination has been a successful tool for the management
of many infectious diseases in cattle and other ruminants, and
paratuberculosis is no exception. Paratuberculosis vaccine
studies have demonstrated the induction of both cellular and
humoral immune responses; however, it is widely accepted that
vaccination will not prevent infection (3, 22, 28). The key
benefits to vaccination are reduced fecal shedding of M. avium
subsp. paratuberculosis (28) and reduced clinical signs in in-
FIG. 6. Percentages of total CD25 T cells (A) and CD4 CD25 T cells (B) cells within total PBMCs of control calves and calves vaccinated with
a heat-killed whole-cell Mycobacterium avium subsp. paratuberculosis vaccine when stimulated with johnin purified protein derivative (JPPD) at
various time points during the 12-month study. Data are expressed as means  SEMs. Significant differences between treatment groups within
given time points are represented by asterisks (*, P 	 0.01; **, P 	 0.05).
2084 STABEL ET AL. CLIN. VACCINE IMMUNOL.
fected animals, with evidence suggesting a reduction in the
incidence of disease within herds (14, 23). Although vaccina-
tion of ruminants is widely used in Europe, the Middle East,
and Australia, less than 10% of dairy operations in the United
States currently vaccinate for Johne’s disease (31). The rising
incidence of Johne’s disease in U.S. dairy herds in recent years
is forcing producers to consider vaccination more carefully as
an additional management tool to prevent the spread of infec-
FIG. 7. Percentages of total CD26 T cells (A) and CD4CD26 T cells (B) cells within total PBMCs of control calves and calves vaccinated with
a heat-killed whole-cell Mycobacterium avium subsp. paratuberculosis vaccine when stimulated with johnin purified protein derivative (JPPD) at
various time points during the 12-month study. Data are expressed as means  SEMs. Significant differences between treatment groups within
given time points are represented by asterisks (*, P 	 0.01; **, P 	 0.05).
FIG. 8. Percentages of total B cells, CD5
 B cells/total B cells, and CD45 RO
 B cells/total B cells within total PBMCs of control calves and calves
vaccinated with a heat-killed whole-cell Mycobacterium avium subsp. paratuberculosis vaccine when stimulated with pokeweed mitogen (PWM), johnin
purified protein derivative (JPPD), and whole-cell sonicate of Mycobacterium avium subsp. paratuberculosis (MPS) at 12 months postvaccination. Data
are expressed as means  SEMs. Significant differences between treatment groups are represented by asterisks (*, P 	 0.01; **, P 	 0.05).
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tion. Control of intracellular infections such as M. avium subsp.
paratuberculosis is generally thought to be the result of Th1-
mediated immunity in the host (24), yet vaccination invokes
both cell-mediated and humoral immune responses (3, 9).
With this in mind, we must consider the utility of current
immune-based diagnostic tools for the detection of Johne’s
disease in vaccinated herds. A major impediment to the use of
vaccination is the potential to result in false-positive interpre-
tation of diagnostic tests for paratuberculosis and bovine tu-
berculosis. With the reemergence of bovine tuberculosis in
U.S. dairy herds, it is critical that a clear interpretation of
infection can be made in herds vaccinated for M. avium subsp.
paratuberculosis.
The present study demonstrated that vaccination with the
Mycopar vaccine elicited strong IFN- responses to M. avium
subsp. paratuberculosis antigens (JPPD and MPS) within 7
days, an effect that was maintained throughout the 12-month
study. This is in agreement with the results of studies evaluat-
ing other whole-cell vaccines (Neoparasec and Gudair) for
Johne’s disease and is suggestive of a protective Th1-mediated
immune response in the host. Similar induction of antigen-
specific IFN- responses has been demonstrated in calves in
the early stages of experimental infection with M. avium subsp.
paratuberculosis, indicating that exposure to M. avium subsp.
paratuberculosis in live or killed form will elicit strong IFN-
responses (27). The use of BoPPD as an antigen in the IFN-
assay resulted in responses that mimicked those of M. avium
subsp. paratuberculosis antigens, including both the robustness
and the persistence of the responses. Parallel reactivities to
JPPD and BoPPD in the IFN- test had previously been shown
in long-term assessment of cattle herds administered a heat-
killed vaccine (19). Although the reactivity to JPPD was stron-
FIG. 9. Serum antibodies to Mycobacterium avium subsp. paratuberculosis in control calves and calves vaccinated with a heat-killed whole-cell
Mycobacterium avium subsp. paratuberculosis vaccine measured by commercial ELISA during the 12-month study. Data are expressed as means  SEMs.
Significant differences between treatment groups within given time points are represented by asterisks (*, P 	 0.01; **, P 	 0.05). S/P ratios,
sample-to-positive ratios.
FIG. 10. Immunoblot of sera from a representative calf in each
treatment group. (A) Control. (B) Vaccinate. Sera were blotted
against the whole-cell sonicate preparation of Mycobacterium avium
subsp. paratuberculosis strain K-10. Lane markings represent days 0, 7,
14, and 28 and the 3-, 6-, 9-, and 12-month sampling times of the study.
Molecular sizes (kDa) are indicated on the left.
FIG. 11. Skinfold thickness increases in response to M. avium pu-
rified protein derivative (AvPPD) and M. bovis purified protein deriv-
ative (BoPPD) in control calves and calves vaccinated with a heat-
killed whole-cell Mycobacterium avium subsp. paratuberculosis vaccine
at 6 months postvaccination. Data are expressed as means  SEMs.
Significant differences between treatment groups within given time
points are represented by asterisks (*, P 	 0.01; **, P 	 0.05).
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ger than for the BoPPD, the reactivities to both PPDs were
robust and diminished at relatively similar rates throughout the
14-year study (19). The close similarities of the BoPPD and M.
avium subsp. paratuberculosis antigen responses would indicate
that these mycobacterial species share some dominant antigens
that may be capitalized upon by vaccination. The present data
suggest that when used as a diagnostic tool for paratuberculo-
sis with the current M. avium subsp. paratuberculosis antigens,
the IFN- test would not distinguish vaccinated animals from
M. avium subsp. paratuberculosis-infected animals. In addition,
if the IFN- test, using BoPPD as the sole antigen, was per-
formed to screen for TB in herds, animals that have been
vaccinated for M. avium subsp. paratuberculosis could be mis-
classified as TB positive. However, the use of the rEC (ESAT-
6/CFP-10) protein complex may provide some discrimination
for this diagnostic test, as there was minimal reactivity dem-
onstrated in the IFN- test at any time point in the study in
vaccinated calves. This suggests that the rEC protein complex
may be useful in differentiating M. avium subsp. paratubercu-
losis vaccinates from TB-infected animals in the field.
Antibody-based diagnostic tests for Johne’s disease are used
widely to screen herds, as they have a rapid readout and are
cost effective (29). However, vaccination with whole-cell prod-
ucts will induce antibody responses that are very similar to
those acquired in natural infection. In the present study, vac-
cination of calves resulted in the appearance of M. avium
subsp. paratuberculosis antibodies within 3 to 4 months of vac-
cination, with strong antibody levels sustained throughout the
12-month study. Few studies are available in the literature
assessing the temporal effects of vaccination on antibody re-
sponses without the added complication of M. avium subsp.
paratuberculosis infection. The induction of M. avium subsp.
paratuberculosis antibody in experimental challenge models
has been addressed in a range of ruminant species and dem-
onstrates a pattern of reactivity that is similar to that seen with
vaccination (3, 4). With this in mind, the use of whole-cell
vaccines may preclude the use of standard serologic tests to
distinguish infected animals from those that have been vacci-
nated. Vaccination for Johne’s disease in the United States
must follow guidelines put forth by the USDA and individual
states, including the use of an organism-based detection
method for screening animals for infection. Developing sub-
unit vaccines would significantly reduce or eliminate some of
the troubling aspects of the whole-cell vaccine without sacri-
ficing beneficial properties. A number of putative antigens
have been identified from M. avium subsp. paratuberculosis,
and several of these immunogens have been evaluated for use
as subunit vaccines, including a 70-kDa heat shock protein, a
novel 74F polyprotein, and a mixture of Ag85 and superoxide
dismutase proteins. These proteins have demonstrated success
in protection against experimental M. avium subsp. paratuber-
culosis challenge but have yet to become commercially avail-
able (7, 15, 16). Interestingly, a decrease in the total B cell
population observed for vaccinated calves after stimulation of
cells with M. avium subsp. paratuberculosis antigens, concom-
itant with an increase in CD5
 and CD45RO
 B cells, could
signal a shift to a more mature, activated subpopulation re-
sponsible for increased antibody production. We did observe
that antigen-stimulated CD5 and CD45RO
 B cells were
maintained throughout the study for vaccinated calves but de-
clined for control calves (data not shown) and that this coin-
cided with the appearance of M. avium subsp. paratuberculosis-
specific antibody.
The bovine tuberculin test, or caudal fold test (CFT), is the
most widely used tool for screening herds for bovine TB and is
based upon a response to BoPPD. However, the comparative
cervical test (CCT) is more definitive, as it characterizes re-
sponses to both BoPPD and AvPPD, thereby allowing the
discrimination of potential false-positive reactors due to expo-
sure to M. avium subsp. paratuberculosis and other environ-
mental mycobacteria. In the present study, vaccinated calves
demonstrated biased reactivities to AvPPD (18.9  5.9) com-
FIG. 12. Scattergram demonstrating skinfold thickness increases (mm) in response to M. avium purified protein derivative (AvPPD) and M.
bovis purified protein derivative (BoPPD) in control calves and calves vaccinated with a heat-killed whole-cell Mycobacterium avium subsp.
paratuberculosis vaccine. The gray zone within the diagram indicates a suspect zone determined by skinfold increase to AvPPD and BoPPD in cattle
and bison. If data points fall to the left or right of the gray zone, animals are considered negative (nonreactors) or M. bovis reactors, respectively.
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pared to their reactivities to BoPPD (6.9  0.9). Using the
standardized formula for categorization, all vaccinated calves
were in the M. bovis-negative zone except for one calf that fell
into the lower end of the suspect zone for cattle/bison. Without
the additional data provided by the AvPPD, it is possible that
vaccinated calves would have been misclassified as TB positive,
since 4/5 calves had indurations greater than 5 mm to BoPPD.
Furthermore, we were able to characterize the status of calves
in the present study with serologic diagnostic tools for bovine
TB. Vaccinated calves did not react on either the STAT-PAK,
DPP VetTB, or DPP BovidTB test, indicating that specific M.
bovis antigens, such as ESAT-6, CFP-10, and MPB83, could be
used to discriminate between bovine TB infections and M.
avium subsp. paratuberculosis vaccinates. This is the first appli-
cation to evaluate these novel TB diagnostic tests in cattle
vaccinated against M. avium subsp. paratuberculosis. Buddle et
al. (6) recently reported that deer vaccinated with a heat-killed
whole-cell vaccine for M. avium subsp. paratuberculosis (Sili-
rum; Pfizer) demonstrated false-positive results on both the
CervidTB STAT-PAK and the DPP VetTB tests at 14 and 26
weeks postvaccination. However, the number of false-positive
reactions increased greatly upon the administration of a CCT
at 20 weeks, suggesting that the skin test boosted serum anti-
body levels. Although all sera from vaccinated calves in the
present study were negative (below cutoff), one vaccinated calf
did develop a weak band on the VetTB STAT-PAK and DPP
VetTB tests at 9 and 12 months. Since the CCT was adminis-
tered to calves at 6 months postvaccination, it is likely that
some moderate boosting of antibody response did occur in this
animal due to the administration of BoPPD in the skin test.
Host responses to paratuberculosis vaccines are associated
with the induction of both Th1 and Th2 immunity as charac-
terized by antigen-specific IFN- responses and M. avium
subsp. paratuberculosis-specific serum antibody, respectively (3,
9, 17, 19, 20). In the present study, more extensive evaluation
of immunologic parameters was performed to further charac-
terize host immune responses to vaccination but, also, to iden-
tify potential markers that might be useful in differentiating
vaccinated and infected animals. Robust IFN- responses were
observed in vaccinated calves, as mentioned above, but secre-
tion of IL-4, IL-10, and IL-12 was not markedly affected by
vaccination. A short-term attenuation of antigen-specific IL-4
and IL-10 secretion was observed within the first 3 months
after vaccination, but whether this effect is meaningful or not is
unknown. Recently, we observed that IL-10 secretion was up-
regulated in both naïve and infected calves after in vitro stim-
ulation of PBMCs with MPS compared to its secretion with nil
stimulation, suggesting that M. avium subsp. paratuberculosis
induces transitory increases in this cytokine that are not de-
pendent upon recall responses to antigen (27).
Largely, T cell populations did not appear to be affected by
vaccination, either in fresh (noncultured) PBMCs or in
PBMCs cultured with mitogens and antigen preparations. An
exception to this was an increase in NK cells in total PBMCs
cultured with JPPD late in the study (9 and 12 months). The
age of the calves may have had an impact, since increases in
NK cells occurred concurrently in both control and vaccinated
calves; however, the degree of increase was greater in vacci-
nated calves. Little work has been done to characterize a role
for natural killer cells in M. avium subsp. paratuberculosis in-
fection, and there has been no documentation of NK cell
populations after vaccination. However, it has been demon-
strated that NK cells produce IFN- in response to M. bovis
and M. avium subsp. paratuberculosis antigens in young calves,
so perhaps this cell population is helping to maintain the high
levels of IFN- noted in vaccinated calves and skewing host
immune responses to a Th1-mediated response (21).
Vaccination did induce significant changes in activation
markers on T cells, with upregulation of both CD25 and CD26
on total T cells and CD4
 T cells. CD4 CD25
 T cells are
highly induced in both experimentally and naturally infected
animals, as well as animals vaccinated for paratuberculosis,
and represent a highly activated T cell subpopulation (9, 22, 25,
27, 33). Coexpression of CD25 and the transcription factor
FoxP3 on CD4
 cells defines T regulatory cells, a subpopula-
tion that is critical in controlling inflammatory responses in the
host (5). In contrast, little is known about the function of CD26
to define bovine immune cell populations. We previously dem-
onstrated a significant upregulation of CD26 on CD4, CD8,
and  T cells within 3 months after experimental infection of
calves that was sustained through a 12-month period (27). This
activation marker is predominantly expressed by cells with a
Th1 phenotype, aligning them with a concerted production of
high levels of IFN-, as noted in the present study.
Vaccination has become a necessary alternative for the man-
agement of paratuberculosis and has been successfully used in
control programs worldwide. Concerns about the interpreta-
tion of diagnostic tests for the detection of M. avium subsp.
paratuberculosis in vaccinated animals are valid, as the present
study demonstrated that vaccination induced sustained IFN-
and serum antibody responses. It is clear that vaccination with
a whole-cell vaccine product induces both Th1- and Th2-me-
diated immune responses in the host. Markers of host immu-
nity that may distinguish M. avium subsp. paratuberculosis in-
fection from vaccination remain elusive, but a more thorough
understanding of the mixed Th1-Th2 responses may provide a
path forward in the identification of a unique marker. In con-
trast, the novel serologic tests for the detection of serum an-
tibodies and the CCT test may be useful in discriminating
between M. bovis-infected animals and those vaccinated for
paratuberculosis. More extensive evaluation of these diagnos-
tic tools should be undertaken in herds vaccinated for paratu-
berculosis to fully understand their stringency.
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